Table IV.
NASH Clinical Research Network (CRN) scoring system for nonalcoholic fatty liver disease (from Kleiner et al., 2005) 19.
| Steatosis grade | Lobular Inflammation | Hepatocellular ballooning | |
|---|---|---|---|
| 0: < 5% | 0: None | 0: None | |
| 1: 5-33% | 1: < 2 foci/20x field | 1: Mild, few | |
| 2: 34-66% | 2-4 foci/20x field | 2: Moderate-marked, many | |
| 3: > 66% | 3: > 4 foci/20x field | ||
| NAFLD activity score (NAS): 0-8 | |||
| Fibrosis (evaluated with Masson trichrome stain) | |||
| 0 | None | ||
| 1a | Mild zone 3 sinusoidal fibrosis (trichrome stain to be identified) | ||
| 1b | Moderate zone 3 sinusoidal fibrosis (could be detected on H&E examination) | ||
| 1c | Portal fibrosis only | ||
| 2 | Zone 3 sinusoidal fibrosis and periportal fibrosis | ||
| 3 | Bridging fibrosis | ||
| 4 | Cirrhosis | ||
NASH: nonalcoholic steatohepatitis; NAFLD, nonalcoholic fatty liver disease.